Q&A With GSK, Veeva & Verix

The pressure is on. With life sciences mergers and acquisitions surging to $70 billion this year to date, business development leaders must cut through incomplete data, subjective judgment, and tight timelines to secure the right deals. Decisive, timely action is the ultimate competitive advantage.

Hear from a commercial strategy and business development executive at GSK about how to move your organization from retrospective searching to predictive evaluation.

Speakers will discuss:

  • How to overcome bottlenecks. Strategies to overcome common friction points in the search and evaluation process.
  • High-value scouting: How to better identify and screen opportunities with speed and agility.
  • The power of prediction: Master the use of real-world data and predictive intelligence to accelerate your decision-making.

Speakers

Headshot 1

Jakub Pijewski, PhD 

VP, US Commercial Strategy, Business Development and External Collaborations
GSK


Headshot 2

Ed Park

VP, Compass Strategy
Veeva

Headshot 3

Vikas Hiremath

VP, Product
Verix